Steven Michael Snyder

US Patent:

8311622, Nov 13, 2012

Filed:

Nov 30, 2006

Appl. No.:

11/565305

Inventors:

Steven M. Snyder - Boulder CO, US
James D. Falk - Duluth MN, US

Assignee:

Neba Health LLC - Augusta GA

International Classification:

A61B 5/0467

US Classification:

600544, 600300

Abstract:

This invention is directed to systems and methods for analyzing depression, and more particularly relates to systems and methods for analyzing and assessing depression and mood disorders in an individual using electroencephalographic measurements. Embodiments of the invention are not limited to depression, but can also include other mood disorders such as bipolar disorder and other disorders with at least one genetic-related component.

US Patent:

8509884, Aug 13, 2013

Filed:

Aug 27, 2010

Appl. No.:

12/870328

Inventors:

Steven M. Snyder - Boulder CO, US

Assignee:

Neba Health LLC - Augusta GA

International Classification:

A61B 5/04

US Classification:

600544, 434236

Abstract:

This invention is directed to embodiments of systems and methods to identify a subgroup of ADHD at higher risk for complicating conditions that, for example, may be of concern to an ADHD evaluation, may account for attention and behavior symptoms, and may lead a clinician to exclusion of ADHD from primary diagnosis. In one embodiment, a method for identifying a subgroup of attention deficit hyperactivity disorder (ADHD) patients at higher risk for complicating conditions is provided. The method can include receiving, from a user or clinician, evaluation data associated with a plurality of patients identified with ADHD as a primary diagnosis; obtaining EEG data for each of the plurality of patients; determining, based at least in part on the EEG data, an indicator of ADHD, wherein the indicator supports a positive or negative ADHD evaluation; correlating the indicator with a user's or clinician's evaluation data; and based at least in part on the correlation, determining at least one subgroup of the plurality of patients, wherein the correlation provides positive support for diagnosis of ADHD or provides support for further testing for complicating conditions before proceeding with diagnosis of ADHD in at least one patient within the at least one subgroup.

US Patent:

20030233250, Dec 18, 2003

Filed:

Feb 18, 2003

Appl. No.:

10/368295

Inventors:

David Joffe - Boulder CO, US
Vincent Colwell - Martinez GA, US
Michael Hickey - Boulder CO, US
Steven Snyder - Boulder CO, US
Stephen Xenakis - Augusta GA, US

International Classification:

G06F017/60

US Classification:

705/002000

Abstract:

The invention includes systems and methods for managing a patient's biological data and providing a data interpretation tool for the biological data via a network. An exemplary system and method includes collecting biological data from a patient; transmitting a portion of the biological data through the network to a storage device; determining at least one potential indicator variable associated with the patient's biological data; comparing the at least one potential indicator variable associated with the patient's biological data to a standardized set of data associated with a health condition; based upon the comparison, selecting at least one indicator variable; and generating a report including the indicator variable and at least one data interpretation tool to a health care provider associated with the patient.

US Patent:

20070299360, Dec 27, 2007

Filed:

Jun 21, 2007

Appl. No.:

11/766615

Inventors:

Steven M. Snyder - Boulder CO, US
James D. Falk - Duluth MN, US

Assignee:

LEXICOR MEDICAL TECHNOLOGY, LLC - Augusta GA

International Classification:

A61B 5/0476

US Classification:

600544

Abstract:

Embodiments of the invention can provide systems and methods for analyzing and assessing dementia and dementia-type disorders by integrating the use of electroencephalography (EEG), neuropsychological or cognitive testing data, and cardiovascular risk factor data. Embodiments of the invention can provide systems and methods for early detection of dementia, including Alzheimer's disease (AD), vascular dementia (VAD), mixed dementia (AD and VAD), MCI, and other dementia-type disorders. Embodiments of the invention can provide some or all of the following improvements over conventional systems and methods, including: (1) Increased sensitivity, specificity, and overall accuracy; (2) Detection of AD, VAD and mixed dementia; and (3) Accurate detection of mild dementia and some cases of mild cognitive impairment in addition to the detection of moderate to severe dementia.

US Patent:

20080269632, Oct 30, 2008

Filed:

Oct 23, 2007

Appl. No.:

11/877357

Inventors:

Steven M. Snyder - Boulder CO, US

Assignee:

LEXICOR MEDICAL TECHNOLOGY, LLC - Augusta GA

International Classification:

A61B 5/0476

US Classification:

600544

Abstract:

Embodiments of the invention can provide systems and methods for analyzing and assessing attention deficit hyperactivity disorder (ADHD) by integrating the use of electroencephalography (EEG), and ADHD diagnostic and assessment tools, such as an ADHD rating scale. Embodiments of the invention can provide some or all of the following improvements over conventional systems and methods, including: (1) Increased sensitivity, specificity, and overall accuracy; (2) Improved detection of ADHD; and (3) Distinguishing subjects with ADHD from subjects with a different disorder but having ADHD-like symptoms, such as attention and behavior symptoms similar to ADHD.

US Patent:

20140051947, Feb 20, 2014

Filed:

Aug 12, 2013

Appl. No.:

13/964352

Inventors:

Steven M. Snyder - Boulder CO, US

Assignee:

NEBA HEALTH LLC - Augusta GA

International Classification:

A61B 5/16
A61B 5/04
A61B 5/00
A61B 5/0476

US Classification:

600301, 600544, 600300

Abstract:

This invention is directed to embodiments of systems and methods to identify a subgroup of ADHD at higher risk for complicating conditions that, for example, may be of concern to an ADHD evaluation, may account for attention and behavior symptoms, and may lead a clinician to exclusion of ADHD from primary diagnosis. In one embodiment, a method for identifying a subgroup of attention deficit hyperactivity disorder (ADHD) patients at higher risk for complicating conditions is provided. The method can include receiving, from a user or clinician, evaluation data associated with a plurality of patients identified with ADHD as a primary diagnosis; obtaining EEG data for each of the plurality of patients; determining, based at least in part on the EEG data, an indicator of ADHD, wherein the indicator supports a positive or negative ADHD evaluation; correlating the indicator with a user's or clinician's evaluation data; and based at least in part on the correlation, determining at least one subgroup of the plurality of patients, wherein the correlation provides positive support for diagnosis of ADHD or provides support for further testing for complicating conditions before proceeding with diagnosis of ADHD in at least one patient within the at least one subgroup.